Zelegent

Zelegent has developed the Elevo Kit Snoring Intervention Device for performing Elevoplasty—a minimally invasive office-based procedure designed to alleviate primary snoring by addressing palatal flutter. Clinical studies have been conducted at multiple US centers. As of the last update, the device was investigational and not yet for sale in the United States[4][5]. In 2017, physicians in 8 US medical centers completed a Zelegent-sponsored multi-center clinical trial... The S.I.L.E.N.C.E. clinical study included both academic institutions and private practitioners...[4] The product has received attention from major ENT specialists and industry partners. Cook Medical entered into an agreement with Zelegent to provide global sales, marketing, and distribution support for Elevoplasty technology[4]. Alphaeon Corp became lead investor via Series A financing and signed an exclusive worldwide commercialization agreement with Zelegent for Elevoplasty technology targeting board-certified sleep specialists[5].